Physician profile
Aaron Giltner
NPI 1750598892
$1,202.28
in general payments reported to CMS, 2019-2025
13 companies · $416 in 2025
The $416 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.88 · 2020: $30.91 · 2021: $319 · 2022: $151 · 2023: $136 · 2024: $137 · 2025: $416.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $689.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $689.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $367.23 | 2019-2025 | Avvigo Guidance System, Rotapro, Eluvia |
| Medtronic, INC. | $125.60 | 2021-2025 | Cobalt Dr Mri Surescan, Linq II, Azure Xt Dr Mri Surescan |
| Biotronik INC. | $121.36 | 2024-2025 | Amvia Edge, Pamira, Acticor 7 Vr-T Dx |
| Amgen INC. | $114.62 | 2021 | |
| Abiomed | $111.73 | 2021-2025 | Impella |
| Cardiovascular Systems INC. | $80.99 | 2022-2023 | |
| Abbott Laboratories | $63.81 | 2021-2025 | Diamondback Peripheral |
| E.R. Squibb & Sons, L.L.C. | $58.69 | 2021-2023 | Eliquis |
| Imperative Care, INC | $57.30 | 2025 | Zoom Reperfusion Catheter |
| Pfizer INC. | $31.31 | 2020-2025 | |
| Impulse Dynamics (USA) INC. | $29.21 | 2022 | |
| Tactile Systems Technology INC | $21.11 | 2025 | Flexitouch Plus, Nimbl |
| Novartis Pharmaceuticals Corporation | $19.32 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Giltner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.